关注
martin bitzan
martin bitzan
在 mcgill.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
An international consensus approach to the management of atypical hemolytic uremic syndrome in children
C Loirat, F Fakhouri, G Ariceta, N Besbas, M Bitzan, A Bjerre, R Coppo, ...
Pediatric nephrology 31, 15-39, 2016
6762016
Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections
H Karch, M Bielaszewska, M Bitzan, H Schmidt
Diagnostic microbiology and infectious disease 34 (3), 229-243, 1999
3131999
Non-enteropathic hemolytic uremic syndrome: causes and short-term course
AR Constantinescu, M Bitzan, LS Weiss, E Christen, BS Kaplan, A Cnaan, ...
American Journal of Kidney Diseases 43 (6), 976-982, 2004
3002004
Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome
F Gunzer, H Böhm, H Rüssmann, M Bitzan, S Aleksic, H Karch
Journal of Clinical microbiology 30 (7), 1807-1810, 1992
2941992
The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: Results of a Central European, multicentre study
M Bitzan, K Ludwig, M Klemt, H König, J Büren, DE Müller-Wiefel
Epidemiology & Infection 110 (2), 183-196, 1993
1901993
High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome
M Bitzan, E Moebius, K Ludwig, DE Müller-Wiefel, J Heesemann, H Karch
The Journal of pediatrics 119 (3), 380-385, 1991
1791991
Molecular Characteristics and Epidemiological Significance of Shiga Toxin-Producing Escherichia coliO26 Strains
WL Zhang, M Bielaszewska, A Liesegang, H Tschäpe, H Schmidt, ...
Journal of Clinical Microbiology 38 (6), 2134-2140, 2000
1612000
Management of hemolytic uremic syndrome
C Loirat, J Saland, M Bitzan
La Presse Médicale 41 (3), e115-e135, 2012
1402012
Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro
M Bitzan, S Richardson, C Huang, B Boyd, M Petric, MA Karmali
Infection and immunity 62 (8), 3337-3347, 1994
1331994
An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome
S Johnson, J Stojanovic, G Ariceta, M Bitzan, N Besbas, M Frieling, ...
Pediatric nephrology 29, 1967-1978, 2014
1292014
Treatment options for HUS secondary to Escherichia coli O157: H7
M Bitzan
Kidney International 75, S62-S66, 2009
1282009
ARHGDIA: a novel gene implicated in nephrotic syndrome
IR Gupta, C Baldwin, D Auguste, KCH Ha, J El Andalousi, S Fahiminiya, ...
Journal of medical genetics 50 (5), 330-338, 2013
1192013
Spectrum of mutations in the renin–angiotensin system genes in autosomal recessive renal tubular dysgenesis
O Gribouval, V Morinière, A Pawtowski, C Arrondel, SL Sallinen, ...
Human mutation 33 (2), 316-326, 2012
1132012
Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteers
M Bitzan, R Poole, M Mehran, E Sicard, C Brockus, C Thuning-Roberson, ...
Antimicrobial Agents and Chemotherapy 53 (7), 3081-3087, 2009
1052009
Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium.
MM Bitzan, Y Wang, J Lin, PA Marsden
The Journal of clinical investigation 101 (2), 372-382, 1998
1041998
Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy
IM Hoffmann, BK Rubin, SS Iskandar, MS Schechter, SK Nagaraj, ...
Pediatric pulmonology 34 (5), 375-377, 2002
1022002
Shiga Toxin-Producing Escherichia coli Infection and Antibodies against Stx2 and Stx1 in Household Contacts of Children with Enteropathic Hemolytic-Uremic …
K Ludwig, V Sarkim, M Bitzan, MA Karmali, C Bobrowski, H Ruder, ...
Journal of clinical microbiology 40 (5), 1773-1782, 2002
1022002
Immune Response to Non-O157 Vero Toxin—Producing Escherichia coli in Patients with Hemolytic Uremic Syndrome
K Ludwig, M Bitzan, S Zimmermann, M Kloth, H Ruder, DE Müller-Wiefel
Journal of Infectious Diseases 174 (5), 1028-1039, 1996
881996
Inhibition of Helicobacter pylori and Helicobacter mustelae Binding to Lipid Receptors by Bovine Colostrum
MM Bitzan, BD Gold, DJ Philpott, M Huesca, PM Sherman, H Karch, ...
Journal of Infectious Diseases 177 (4), 955-961, 1998
871998
Treatment of typical (enteropathic) hemolytic uremic syndrome
M Bitzan, F Schaefer, D Reymond
Seminars in thrombosis and hemostasis 36 (06), 594-610, 2010
852010
系统目前无法执行此操作,请稍后再试。
文章 1–20